Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Tipus de document

Tesi

Versió

Versió publicada

Data de publicació

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/220465

CPEB4 regulation of vasculogenic mimicry in liver cancer: mechanisms and therapeutic implications

Títol de la revista

ISSN de la revista

Títol del volum

Recurs relacionat

Resum

[eng] BACKGROUND: Hepatocellular carcinoma (HCC) poses a significant clinical challenge due to its complex vascular abnormalities and the regulatory mechanisms underlying tumor progression. Vasculogenic mimicry (VM), a neovascularization process where cancer cells form vessel-like structures, remains poorly understood in HCC. Cytoplasmic polyadenylation element binding protein 4 (CPEB4) is a critical regulator of mRNA translation. This study aims to elucidate the role of CPEB4 in VM and its potential impact on resistance to anti-angiogenic therapies in HCC. OBJECTIVES: The objectives of this research were (1) to investigate the capacity of liver cancer cells to perform VM both in vitro and in vivo. (2) To explore the role and underlying mechanisms of CPEB4 in regulating VM. (3) To determine whether CPEB4 affects the pro-angiogenic profile of liver cancer cells. (4) To assess the role of VM in mediating resistance to anti-angiogenic the

Citació

Citació

IRALDE CÁRDENAS, Beatriz. CPEB4 regulation of vasculogenic mimicry in liver cancer: mechanisms and therapeutic implications. [consulted: 19 of August of 2026]. Available at: https://hdl.handle.net/2445/220465

Exportar metadades

JSON - METS

Compartir registre